SynDevRx Assembles Prostate Cancer Medical Advisory Board to Oversee...

The Board will provide insight and experience during the development of SDX-7320 across multiple lines of treatment for androgen sensitive and castration resistant prostate cancer.(PRWeb January 25, 2021)Read the full story at https://www.prweb.com/releases/syndevrx_assembles_prostate_cancer_medical_advisory_board_to_oversee_drug_candidate_that_targets_link_between_obesity_and_prostate_cancer/prweb17672402.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news